EurekaMag.com logo
+ Translate

Evidence of a modifying influence of heart glucosides on the development of breast cancer


, : Evidence of a modifying influence of heart glucosides on the development of breast cancer. Analytical and Quantitative Cytology 2(1): 49-54

Patients on digitalis medication at the time of diagnosis of breast cancer seem to develop tumors that have a lower growth potential than do patients not on such medication.

(PDF 0-2 workdays service)

Order PDF Full Text

Close
Close

Click here to order any other PDF Full Text


Accession: 005411114

PMID: 7377665

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Beamer, W.; Yang, X.F.ng; Huynh, H.; Pollak, M., 1996: Reduced growth of human breast cancer xenografts in murine hosts homozygous for the lit mutation provides evidence for influence of host IGF-1 physiology on breast cancer behaviour. Proceedings of the American Association for Cancer Research Annual Meeting 37(0): 260

Piggott, R.P.; Waters, P.S.; Kerin, M.J., 2016: The influence of breast cancer subtype on bone metastases development and survival in women with metastatic breast cancer. Tumour metastatic disease reflects a complex interplay between tumour characteristics and local host factors. This complex relationship may have an influence on the development of metastatic disease and patient survival. Multiple factors of the pr...

John, E.M.; Phipps, A.I.; Sangaramoorthy, M., 2013: Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study. Data on body size and postmenopausal breast cancer in Hispanic and African American women are inconsistent, possibly due to the influence of modifying factors. We examined associations between adiposity and risk of breast cancer defined by hormone...

Coopey, S.B.; Mazzola, E.; Buckley, J.M.; Sharko, J.; Belli, A.K.; Kim, E.M.H.; Polubriaginof, F.; Parmigiani, G.; Garber, J.E.; Smith, B.L.; Gadd, M.A.; Specht, M.C.; Guidi, A.J.; Roche, C.A.; Hughes, K.S., 2013: The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Women with atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS), and severe ADH are at increased risk of breast cancer, but a systematic quantification of this risk and the efficacy of chemopreven...

Jackson, L.R.; Cheung, K.L.; Buzdar, A.U.; Robertson, J.F.R., 2008: Arzoxifene: the evidence for its development in the management of breast cancer. Endocrine therapy is an important and integral part of breast cancer management. Selective estrogen receptor modulators (SERMs), such as tamoxifen, remain a vital component in the endocrine therapy armamentarium. However the "ideal SERM"...

Va.R.Menant.M.; Tagnon.H., 1958: Role of hormones as modifying agents of the hormonal status in cancer; hormone therapy of generalized breast cancer. Acta Chirurgica Belgica 57(Suppl 1): 79-129

Duma, M.N.; Molls, M.; Trott, K.R., 2014: From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy. Strahlentherapie und Onkologie 190(1): 5-7

Williams, M.; Hrazdina, G.; Wilkinson, M.M.; Sweeny, J.G.; Iacobucci, G.A., 1978: High pressure liquid chromatographic separation of 3 glucosides 3 5 di glucosides 3 6 o p coumaryl glucosides and 3 6 o p coumaryl glucoside 5 glucosides of antho cyanidins. A high-pressure liquid chromatographic method was developed for separation of anthocyanins from fruits [grape] and their products on a .mu.Bondapak C18 analytical column. Separation of 3- and 3,5-diglucosides of anthocyanidins was achieved with aq...

Smets, W.; Dor, P., 1958: Role of surgery as a modifying agent of the hormonal status in cancer; surgical palliative treatment of generalized breast cancer. Acta Chirurgica Belgica 57(Suppl 1): 131-237

Hille-Betz, U.; Vaske, B.; Bremer, M.; Soergel, P.; Kundu, S.; Klapdor, Rüdiger.; Hillemanns, P.; Henkenberens, C., 2016: Late radiation side effects, cosmetic outcomes and pain in breast cancer patients after breast-conserving surgery and three-dimensional conformal radiotherapy : Risk-modifying factors. The purpose of this work was to identify parameters influencing the risk of late radiation side effects, fair or poor cosmetic outcomes (COs) and pain in breast cancer patients after breast-conserving therapy (BCT) and three-dimensional conformal...